exemestane (Compound)

Synonyms:EXEMESTANE, 107868-30-4, Aromasin, 6-Methyleneandrosta-1,4-diene-3,17-dione, Fce 24304, Exemestano, Exemestanum, Exemestanum [INN-Latin], Exemestano [INN-Spanish], FCE-24304, 6-Methylene-androsta-1,4-diene-3,17-dione, UNII-NY22HMQ4BX, Androsta-1,4-diene-3,17-dione, 6-methylene-, 6-methylideneandrosta-1,4-diene-3,17-dione, FCE24304, Aromasine, NY22HMQ4BX, PNU-155971, CHEBI:4953, (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione, (8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione, Aromasil, NSC713563, (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione, EXE, DSSTox_CID_3037, DSSTox_RID_76844, DSSTox_GSID_23037, Exemestane [USAN:INN:BAN], Nikidess, (8alpha,10alpha,13alpha)-6-Methylideneandrosta-1,4-Diene-3,17-Dione, Aromasin (TN), SMR000466314, CAS-107868-30-4, HSDB 7463, Curator_000009, Exemestane (JAN/USP/INN), CCRIS 9351, NCGC00095289-01, Exemestane; aromasin, Exemestane, Aromasin, PNU 155971, SCHEMBL6215, Aromasin (Pharmacia Upjohn), Exemestane(FCE 24304), MLS000759419, MLS001424062, GTPL7073, 6-Methylenandrosta-1,17-dione, CHEMBL1200374, DTXSID5023037, Exemestane, >=98% (HPLC), AOB5604, SYN3023, BCPP000235, HMS2051J04, HMS3713H12, BCP23353, ZINC3973334, Tox21_111499, BDBM50398447, MFCD00866994, PNU155971, s1196, AKOS015840113, AKOS015895161, Tox21_111499_1, AC-2171, BCP9000676, CCG-100995, CS-1766, DB00990, KS-5136, NC00245, NSC 758907, NSC-713563, NCGC00271596-03, 6-methylenandrost-1,4-dien-3,17-dione, AS-31053, CPD000466314, HY-13632, BCP0726000226, 6-Methylen-androst-1,4-diene-3,17-dione, AB0063735, E0941, C08162, D00963, AB00639936-06, AB00639936-08, AB00639936-09, AB00639936-10, AB00639936_11, 868E304, A801772, Q418819, SR-01000759393, SR-01000759393-4, BRD-K33425534-001-12-5, Exemestane, European Pharmacopoeia (EP) Reference Standard, Exemestane, United States Pharmacopeia (USP) Reference Standard

Pubchem:PUBCHEM:16667705

Id:dabe5969-a69b-5774-aed6-977424edd6e4

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View exemestane's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for exemestane.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with exemestane.

Results found

Linked to

	Label	Description
	exemestane (ec31f85a-c8e9-4f6b-8f4c-48c7db3ca08b) Collection (Entity type)	Metadatata for exemestane
	exemestane (a51b65e0-6c12-44cf-ba9e-41b3e5d5ad45) Collection (Entity type)	Metadatata for exemestane
	DCSTRUCT ID 01122 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01122; PubChem_CID:60198, FILE=drugcentral_drug_01122.json)
	exemestane positively regulates AKR1C3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	exemestane negatively regulates IFITM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	exemestane positively regulates TXNRD1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	exemestane negatively regulates TXNIP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Exemestane indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	exemestane positively regulates KRT15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	exemestane positively regulates ME1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS